Virtu Financial LLC cut its holdings in shares of Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) by 2.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,385 shares of the company’s stock after selling 542 shares during the period. Virtu Financial LLC’s holdings in Celsius were worth $733,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in CELH. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Celsius during the 3rd quarter worth approximately $34,000. Signaturefd LLC increased its position in shares of Celsius by 48.3% during the third quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock worth $36,000 after acquiring an additional 378 shares during the period. Benjamin F. Edwards & Company Inc. raised its stake in shares of Celsius by 353.1% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock valued at $37,000 after acquiring an additional 505 shares in the last quarter. Newbridge Financial Services Group Inc. grew its stake in Celsius by 3,150.0% during the 2nd quarter. Newbridge Financial Services Group Inc. now owns 650 shares of the company’s stock worth $37,000 after purchasing an additional 630 shares in the last quarter. Finally, Activest Wealth Management acquired a new position in Celsius during the 3rd quarter worth $39,000. Institutional investors and hedge funds own 60.95% of the company’s stock.
Wall Street Analysts Forecast Growth
CELH has been the subject of several recent research reports. UBS Group decreased their price objective on Celsius from $50.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, November 7th. Deutsche Bank Aktiengesellschaft began coverage on shares of Celsius in a report on Thursday. They set a “hold” rating and a $32.00 price target for the company. Truist Financial raised their price objective on shares of Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a report on Wednesday, October 16th. Stifel Nicolaus lowered their target price on shares of Celsius from $51.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, November 7th. Finally, Roth Mkm dropped their target price on Celsius from $43.00 to $40.00 and set a “buy” rating on the stock in a report on Thursday, November 7th. One analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $51.28.
Celsius Trading Down 0.6 %
Shares of CELH opened at $31.79 on Friday. The company’s 50 day simple moving average is $30.05 and its 200-day simple moving average is $41.44. The firm has a market cap of $7.47 billion, a PE ratio of 44.15, a price-to-earnings-growth ratio of 3.44 and a beta of 1.76. Celsius Holdings, Inc. has a 12-month low of $25.23 and a 12-month high of $99.62.
Celsius Company Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Articles
- Five stocks we like better than Celsius
- What Are Dividends? Buy the Best Dividend Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- When to Sell a Stock for Profit or Loss
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding CELH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celsius Holdings, Inc. (NASDAQ:CELH – Free Report).
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.